-
Product Insights
CFR SA – Caransebes-Timisoara-Arad Railway Line Upgrade – Caras-Severin
Equip yourself with the essential tools needed to make informed and profitable decisions with our CFR SA - Caransebes-Timisoara-Arad Railway Line Upgrade - Caras-Severin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
ECG Monitoring Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Electrocardiogram (ECG) Monitoring Equipment Pipeline Market Report Overview Electrocardiogram (ECG) Monitoring Equipment records the electrocardiogram (ECG) and is used to evaluate 10 seconds (or a specific time interval) of electrical activity of the heart so a physician can determine the condition of a patient's heart. The ECG Monitoring Equipment pipeline market research report provides comprehensive information about the ECG Monitoring Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials...
-
Company Profile
Recipe Unlimited Corp – Company Profile
Recipe Unlimited Corp (Recipe), formerly Cara Operations Ltd is a food service company that owns and franchises restaurants under Swiss Chalet, Milestones, Montana’s, Kelsey’s, Harvey’s, East Side Mario’s, Prime Pubs, St-Hubert, The KEG, Original Joe’s, New York fries, and State & Main brand names. It also operates under The Pickle Barrel, The Landing Group, Bier Market, Elephant & Castle, The Burger’s Priest, 1909 Taverne Modern, The Landing Group, and Rose Reisman Catering brand names. The company has a presence in...
Add to Basket -
Product Insights
Net Present Value Model: Korsuva IV
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Korsuva IV Drug Details Difelikefalin Acetate...
-
Product Insights
Net Present Value Model: Korsuva Oral
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Korsuva Oral Drug Details Difelikefalin Acetate...
-
Track & Monitor
Innovation in Pharmaceuticals: Tetrapeptide derivatives
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Tetrapeptide derivatives segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
Digital Health Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027
The digital health in immunology market size was valued at US$6.07 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during 2022-2027. Digital health has a broad scope and includes the use of wearable devices, mobile health, telehealth, health information technology, and telemedicine. Digital health applications in immunology have gained significant momentum owing to the following factors: Enhanced access to healthcare Affordable cost of healthcare Improve the quality of care Reduce any...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – difelikefalin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry difelikefalin Drug Details Difelikefalin Acetate (Korsuva, Kapruvia) is a antipruritic agent. It is formulated...
-
Product Insights
Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology comprises of reagents, and test kits to detect the pathogenicity of bacteria such as chlamydia, gonococci, syphilis, helicobacter pylori, salmonella and so on. The bacteriology pipeline market research report provides comprehensive information about the bacteriology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments, infection, dry skin and reaction to a drug. Symptoms include redness, bumps, spots or blisters, dry, cracked skin and leathery or scaly texture to the skin. Risk factors include heat, allergic, asthma, hay fever, hives and eczema. Treatment includes corticosteroids, antihistamines and antidepressants. The Pruritus- Drugs in Development research report provides a comprehensive overview on the therapeutics under...